0000000000214763

AUTHOR

Matteo Orrico

showing 3 related works from this author

Popliteal Artery Aneurysm Repair in the Endovascular Era: Fourteen-Years Single Center Experience

2015

Abstract To compare outcomes of popliteal artery aneurysm (PAA) repair by endovascular treatment, great saphenous vein (GSV) bypass, and prosthetic bypass. Single center retrospective analysis of patients presenting PAA from 2000 to 2013. Patients were divided into endovascular treatment (group A); GSV bypass (group B); and prosthetic graft bypass (group C). Outcomes were technical success, perioperative mortality, and morbidity. Survival, primary and secondary patency, and freedom from reintervention rate were estimated. Differences in ankle-brachial index (ABI), in-hospital length of stay (InH-Los), red blood cell (RBC) transfusion, and limb loss were reported. Mean follow-up was 49 (medi…

Malemedicine.medical_specialtyTime Factors7100Observational Study610 Medicine & health2700 General MedicineSingle CenterSettore MED/22 - Chirurgia VascolareGroup Blaw.inventionBlood Vessel Prosthesis ImplantationAneurysmRandomized controlled triallawmedicine.arteryPopliteal Artery AneurysmmedicineHumansPopliteal ArteryAgedRetrospective Studiesbusiness.industryGreat saphenous veinEndovascular ProceduresAngiographyRetrospective cohort studyGeneral MedicinePerioperativeMiddle Agedmedicine.diseaseAneurysmPopliteal artery10020 Clinic for Cardiac SurgerySurgeryTreatment OutcomeSurgery Computer-AssistedAnesthesiaFluoroscopyFemaleStentsbusinessFollow-Up StudiesForecastingResearch Article
researchProduct

Surgical conversion with graft salvage as a definitive treatment for persistent type II endoleak causing sacenlargement

2015

Objective The goal of this study was to present open surgical conversion with graft salvage or "semiconversion" as a definitive and safe treatment for untreatable and persistent type II endoleaks causing sac enlargement after endovascular aneurysm repair. Methods Between January 2001 and December 2014, 25 of 1623 endovascular aortic repair (EVAR) patients were selected as candidates for open semiconversion. The indication was persistent type II endoleak in 13 patients (12 of whom received previous attempts of embolization), type I and II endoleak in 2 patients, and sac growth without imaging evidence of endoleak in the other 10. After the infrarenal aorta was prepared (via a retroperitoneal…

Malemedicine.medical_specialtygraft salvageEndoleakmedicine.medical_treatmentSurgical conversionEndovascular aneurysm repairSettore MED/22 - Chirurgia VascolareBlood Vessel Prosthesis ImplantationAneurysmmedicineHumansEffective treatmentEmbolizationThrombusbusiness.industryMedicine (all)Patient SelectionEndovascular ProceduresPerioperativeCardiology and Cardiovascular Medicine; Surgerymedicine.diseaseConversion to Open SurgerySize increaseSurgeryEmergency conditionFemaleSurgerySurgical conversion; graft salvage; type II endoleakRadiologytype II endoleakCardiology and Cardiovascular MedicinebusinessConversion to Open Surgery; Endoleak; Endovascular Procedures; Female; Humans; Male; Patient Selection; Blood Vessel Prosthesis Implantation; Cardiology and Cardiovascular Medicine; Surgery; Medicine (all)
researchProduct

Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.

2021

Summary Background Among asymptomatic patients with severe carotid artery stenosis but no recent stroke or transient cerebral ischaemia, either carotid artery stenting (CAS) or carotid endarterectomy (CEA) can restore patency and reduce long-term stroke risks. However, from recent national registry data, each option causes about 1% procedural risk of disabling stroke or death. Comparison of their long-term protective effects requires large-scale randomised evidence. Methods ACST-2 is an international multicentre randomised trial of CAS versus CEA among asymptomatic patients with severe stenosis thought to require intervention, interpreted with all other relevant trials. Patients were eligib…

Malemedicine.medical_specialtyTime FactorsTime Factormedicine.medical_treatmentCarotid StenosiMEDLINECarotid endarterectomyRate ratioRisk AssessmentAsymptomaticlaw.inventionRandomized controlled triallawRisk Factorscarotid artery stenting (CAS); carotid endarterectomy (CEA)StentmedicineHumansCarotid StenosisStrokeEndarterectomyAgedEndarterectomy Carotidbusiness.industrycarotid arteryRisk FactorArticlesGeneral Medicinetrialmedicine.diseaseSettore MED/22 - CHIRURGIA VASCOLARESurgeryStrokeStenosisTreatment Outcomecarotid artery stenting (CAS)Settore MED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREFemaleStentsHuman medicinemedicine.symptomcarotid endarterectomy (CEA)businessHumanLancet (London, England)
researchProduct